Stryker, NuVasive in spine: 5 key comparisons

Laura Dyrda -   Print  |

NuVasive and Stryker are among the top five companies leading the spine market and have continued to grow in the past 12 months.

1. 2019 spine revenue

NuVasive: $1.17 billion, up 7 percent year over year
Stryker: $1 billion, up 28 percent year over year

2. Quarterly spine revenue
Stryker: $261 million (3.5 percent decrease)
NuVasive: $259.9 million (5.4 percent decrease)

3. Market share
NuVasive: 13 percent
Stryker: 12 percent

*According to The Spine Market Group.

4. Leadership
Spencer Stiles is the group president of orthopedics and spine at Stryker, a role he took on in August 2019. He oversees the company's joint replacement, trauma and extremities and spine businesses. He joined Stryker in 1999 and has spent four years as president of spine before becoming the group president of neurotechnology, instruments and spine.

Chris Barry is the CEO of NuVasive, a role he took on in 2018 after spending time as senior vice president and president of surgical innovations at Medtronic. While with Medtronic, he oversaw the $5.5 billion business unit for three years and led a team of 14,000 employees.

5. Big moves
NuVasive: On June 18, NuVasive launched Reline 3D, a posterior fixation system for pediatric spinal deformities, in the U.S. It aims to launch the device in other countries next year. In May, the company also achieved two FDA clearances for two spine devices, the Modulus ALIF and Cohere TLIF-O, and launched the Modulus XLIF dual sided plate.

Stryker: In October 2019, Stryker acquired Mobius Imaging and Cardan Robotics to strengthen its presence in the orthopedics, spine and neurotechnology robotics space. It also acquired OrthoSpace in March 2019 for up to $220 million.

More articles on devices:
Setting spine practices up for success post-pandemic: 5 industry insights
UAMS begins data gathering initiative with spine patients
3 spine surgeons on the move in June

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers